| Title |
Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis
|
|---|---|
| Published in |
Drugs, November 2018
|
| DOI | 10.1007/s40265-018-0992-5 |
| Pubmed ID | |
| Authors |
Simona Lattanzi, Francesco Brigo, Eugen Trinka, Gaetano Zaccara, Claudia Cagnetti, Cinzia Del Giovane, Mauro Silvestrini |
X Demographics
The data shown below were collected from the profiles of 46 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 13% |
| United Kingdom | 5 | 11% |
| Canada | 4 | 9% |
| Spain | 3 | 7% |
| Colombia | 3 | 7% |
| Japan | 2 | 4% |
| France | 1 | 2% |
| Australia | 1 | 2% |
| New Zealand | 1 | 2% |
| Other | 1 | 2% |
| Unknown | 19 | 41% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 40 | 87% |
| Practitioners (doctors, other healthcare professionals) | 3 | 7% |
| Science communicators (journalists, bloggers, editors) | 2 | 4% |
| Scientists | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 399 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 399 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 57 | 14% |
| Student > Master | 44 | 11% |
| Researcher | 38 | 10% |
| Student > Ph. D. Student | 34 | 9% |
| Other | 28 | 7% |
| Other | 68 | 17% |
| Unknown | 130 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 84 | 21% |
| Pharmacology, Toxicology and Pharmaceutical Science | 41 | 10% |
| Neuroscience | 21 | 5% |
| Biochemistry, Genetics and Molecular Biology | 20 | 5% |
| Psychology | 19 | 5% |
| Other | 60 | 15% |
| Unknown | 154 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 84. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 November 2023.
All research outputs
#513,285
of 25,601,426 outputs
Outputs from Drugs
#38
of 3,475 outputs
Outputs of similar age
#11,190
of 365,312 outputs
Outputs of similar age from Drugs
#1
of 35 outputs
Altmetric has tracked 25,601,426 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,475 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.0. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,312 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.